Neola Medical ABOSTO:NEOLA -2.17%28 Pretax Margin % is % as of Dec. 2025. GuruFocus rates OSTO:NEOLA with a GF Score™ of 28/100. The stock has 1 warning sign investors should review. Among 814 Medical Devices & Instruments companies, Neola Medical AB ranks worse than 122850% on this metric.
The historical rank and industry rank for Neola Medical AB's Pretax Margin % or its related term are showing as below:
OSTO:NEOLA's Pretax Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.505 * Ranked among companies with meaningful Pretax Margin % only.
Neola Medical AB (OSTO:NEOLA) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Neola Medical AB Pretax Margin % Related Terms
Neola Medical AB Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Neola Medical AB's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:NEOLA vs ABT, SYK, MDT: Pretax Margin % Comparison
For the Medical Devices subindustry, Neola Medical AB's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neola Medical AB Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Neola Medical AB's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Neola Medical AB's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neola Medical AB (OSTO:NEOLA) has a Pretax Margin % of % as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Neola Medical AB and its competitors. According to the industry distribution chart, Neola Medical AB ranks #999999 out of 814 companies in the Medical Devices & Instruments industry.
Is Neola Medical AB's Pretax Margin % too high?
Neola Medical AB's current Pretax Margin % is %. Based on the distribution chart, Neola Medical AB ranks #999999 out of 814 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Neola Medical AB has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Neola Medical AB's Pretax Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Neola Medical AB ranks #999999 out of 814 companies for Pretax Margin %. This places Neola Medical AB in the lower half of its industry. The industry median Pretax Margin % is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.51, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Neola Medical AB and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neola Medical AB's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neola Medical AB stock overvalued right now?
Neola Medical AB (OSTO:NEOLA) has a current Pretax Margin % of %. The current Pretax Margin % is %. Neola Medical AB's overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Neola Medical AB (OSTO:NEOLA), the current Pretax Margin % is % as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Neola Medical AB is revolutionizing neonatal intensive care with NEOLA, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a technology that measures lung volume changes and oxygen gas concentration. NEOLA has the potential to provide care, fewer days in intensive care, and healthier lives for preterm born infants. The company is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to health care.
28GF Score
Get the complete analysis for OSTO:NEOLA
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:NEOLA has been successfully added to your 
